Publication | Closed Access
Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys
168
Citations
21
References
2005
Year
The excellent safety and efficacy profile of IMMU-110 supports clinical testing of this immunoconjugate in the treatment of CD74-positive B-cell malignancies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1